(MENAFN- IMARC Group)
According to IMARC Group's latest research report, titled “Intragastric Balloons Market: Global industry Trends, Share, Size Growth, Opportunity and Forecast 2024-2032,” provides an extensive analysis of the industry, including intragastric balloons market report . The report also covers competitor and regional analysis and the latest advancements in the global market.
The global intragastric balloons market size reached US$ 63.6 Million in 2023 . Looking forward, IMARC Group expects the market to reach US$ 157.8 Million by 2032 , exhibiting a growth rate (CAGR) of 10.3% during 2024-2032 .
Intragastric Balloons Market Overview:
An intragastric balloon is a medical device designed to aid in weight loss by occupying space within the stomach, thereby inducing a feeling of fullness, and reducing food intake. It is a non-surgical, minimally invasive option for individuals struggling with obesity or those who need to lose a significant amount of weight for health reasons. The balloon is typically inserted into the stomach through the mouth and esophagus, and then filled with a sterile solution, such as saline, to expand and take up space. Intragastric balloons offer advantages such as avoiding surgical incisions, shorter recovery times, and fewer potential complications compared to more invasive weight loss surgeries. They are often recommended for individuals who do not meet the criteria for surgery or prefer a reversible option.
Get Sample Copy of Report at – https://www.imarcgroup.com/intragastric-balloons-market/requestsample
Intragastric Balloons Market Growth:
The global market is driven by the increasing prevalence of obesity and the growing demand for minimally invasive weight loss solutions. Intragastric balloons are non-surgical medical devices inserted into the stomach to promote weight loss by reducing the available space for food intake, thereby inducing a feeling of fullness. As obesity rates continue to rise globally, especially in developed countries, the need for effective and less invasive interventions has led to the growing popularity of intragastric balloons. Changing lifestyles, sedentary habits, and unhealthy dietary choices have contributed to the obesity epidemic, which is linked to various health complications, including diabetes, cardiovascular diseases, and joint problems. Advancements in balloon design and materials have improved their safety, efficacy, and comfort for patients.
Competitive Landscape with Key Players:
Apollo Endosurgery Obalon Therapeutics Inc. ReShape Medical Inc. Medicone Medsil Allurion Technologies Inc. Helioscopie Spatz Fgia Inc. PlenSat Districlass Medical SA Endalis Lexel SRL Silimed Inc. Shandong Institute of Medical Instruments
Key Market Segmentation:
Breakup by Product:
Single Intragastric Balloon Double Intragastric Balloon Triple Intragastric Balloon
Breakup by Filling Material:
Saline Filling Gas Filling
Breakup by Implanting Procedure:
Breakup by Application:
Obesity Diabetes Diet Control Weight-Loss Pre-Operative Weight Reduction Others
Breakup by End-User:
Hospitals and Clinics Ambulatory Surgical Centers Others
Breakup by Region:
North America (United States, Canada) Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others) Europe (Germany, France, United Kingdom, Italy, Spain, Others) Latin America (Brazil, Mexico, Others) Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
Market Performance Market Outlook Porter's Five Forces Analysis Market Drivers and Success Factors SWOT Analysis Value Chain Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email:
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
MENAFN28022024004122016232ID1107911080
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.